Tech Company Financing Transactions

Sagimet Biosciences Funding Round

Altium Capital, Ascletis and HM Capital participated in a $80 million funding round for Sagimet Biosciences. The round was announced on 2/17/2021.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Funds raised will support the advancement of TVB-2640, an oral, first-in-class fatty acid synthase (FASN) inhibitor, including a planned Phase 2b trial evaluating the impact on histological endpoints.

Company Information

Company Status
Private & Independent
Mailing Address
155 Bovet Rd. 303
San Mateo, CA 94402
Email Address
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.
Sagimet Biosciences LinkedIn Company Profile
Social Media
Sagimet Biosciences Company Twitter Account
Company News
Sagimet Biosciences News
Sagimet Biosciences on Facebook
Sagimet Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
George Kemble
  George Kemble LinkedIn Profile  George Kemble Twitter Account  George Kemble News  George Kemble on Facebook
Chief Financial Officer
Dennis Hom
  Dennis Hom LinkedIn Profile  Dennis Hom Twitter Account  Dennis Hom News  Dennis Hom on Facebook
Chief Medical Officer
William McCulloch
  William McCulloch LinkedIn Profile  William McCulloch Twitter Account  William McCulloch News  William McCulloch on Facebook
VP - R & D
Marie O'Farrell
  Marie O'Farrell LinkedIn Profile  Marie O'Farrell Twitter Account  Marie O'Farrell News  Marie O'Farrell on Facebook



Browse more venture capital transactions:

Prev: 2/17/2021: Strata Identity venture capital transaction
Next: 2/17/2021: Spark Microsystems venture capital transaction


Share this article


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary